ID   KPYM_RAT                Reviewed;         531 AA.
AC   P11980; P11981;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-OCT-2024, entry version 208.
DE   RecName: Full=Pyruvate kinase PKM;
DE            EC=2.7.1.40 {ECO:0000250|UniProtKB:P14618};
DE   AltName: Full=Pyruvate kinase muscle isozyme;
DE   AltName: Full=Threonine-protein kinase PKM2 {ECO:0000305};
DE            EC=2.7.11.1 {ECO:0000250|UniProtKB:P14618};
DE   AltName: Full=Tyrosine-protein kinase PKM2 {ECO:0000305};
DE            EC=2.7.10.2 {ECO:0000250|UniProtKB:P14618};
GN   Name=Pkm; Synonyms=Pkm2, Pykm;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS M1 AND M2).
RX   PubMed=3020052; DOI=10.1016/s0021-9258(18)67091-7;
RA   Noguchi T., Inoue H., Tanaka T.;
RT   "The M1- and M2-type isozymes of rat pyruvate kinase are produced from the
RT   same gene by alternative RNA splicing.";
RL   J. Biol. Chem. 261:13807-13812(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS M1 AND M2), AND SEQUENCE
RP   REVISION.
RX   PubMed=2914912; DOI=10.1016/s0021-9258(18)94185-2;
RA   Takenaka M., Noguchi T., Inoue H., Yamada K., Matsuda T., Tanaka T.;
RT   "Rat pyruvate kinase M gene: its complete structure and characterization of
RT   the 5'-flanking region.";
RL   J. Biol. Chem. 264:2363-2367(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM M1).
RC   TISSUE=Pituitary;
RX   PubMed=2780321; DOI=10.1093/nar/17.17.7106;
RA   Parkinson C., Kato H., Cheng S.;
RT   "The nucleotide sequence of a full length cDNA encoding rat pituitary
RT   pyruvate kinase.";
RL   Nucleic Acids Res. 17:7106-7106(1989).
RN   [4]
RP   PROTEIN SEQUENCE OF 33-56; 74-89; 93-115; 174-186; 208-246; 279-294;
RP   343-376; 393-400; 423-436; 476-498 AND 505-526, PROTEIN SEQUENCE OF 384-399
RP   (ISOFORM M2), AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain, Hippocampus, and Spinal cord;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Kang S.U.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97 AND SER-100, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Catalyzes the final rate-limiting step of glycolysis by
CC       mediating the transfer of a phosphoryl group from phosphoenolpyruvate
CC       (PEP) to ADP, generating ATP. The ratio between the highly active
CC       tetrameric form and nearly inactive dimeric form determines whether
CC       glucose carbons are channeled to biosynthetic processes or used for
CC       glycolytic ATP production. The transition between the 2 forms
CC       contributes to the control of glycolysis and is important for tumor
CC       cell proliferation and survival. {ECO:0000250|UniProtKB:P14618}.
CC   -!- FUNCTION: [Isoform M2]: Isoform specifically expressed during
CC       embryogenesis that has low pyruvate kinase activity by itself and
CC       requires allosteric activation by D-fructose 1,6-bisphosphate (FBP) for
CC       pyruvate kinase activity. In addition to its pyruvate kinase activity
CC       in the cytoplasm, also acts as a regulator of transcription in the
CC       nucleus by acting as a protein kinase. Translocates into the nucleus in
CC       response to various signals, such as EGF receptor activation, and
CC       homodimerizes, leading to its conversion into a protein threonine- and
CC       tyrosine-protein kinase. Catalyzes phosphorylation of STAT3 at 'Tyr-
CC       705' and histone H3 at 'Thr-11' (H3T11ph), leading to activate
CC       transcription. Its ability to activate transcription plays a role in
CC       cancer cells by promoting cell proliferation and promote tumorigenesis
CC       (By similarity). Promotes the expression of the immune checkpoint
CC       protein CD274 in BMAL1-deficient macrophages. May also act as a
CC       translation regulator for a subset of mRNAs, independently of its
CC       pyruvate kinase activity: associates with subpools of endoplasmic
CC       reticulum-associated ribosomes, binds directly to the mRNAs translated
CC       at the endoplasmic reticulum and promotes translation of these
CC       endoplasmic reticulum-destined mRNAs (By similarity). Plays a role in
CC       caspase independent cell death of tumor cells (By similarity).
CC       {ECO:0000250|UniProtKB:P14618, ECO:0000250|UniProtKB:P52480}.
CC   -!- FUNCTION: [Isoform M1]: Pyruvate kinase isoform expressed in adult
CC       tissues, which replaces isoform M2 after birth. In contrast to isoform
CC       M2, has high pyruvate kinase activity by itself and does not require
CC       allosteric activation by D-fructose 1,6-bisphosphate (FBP) for
CC       activity. {ECO:0000250|UniProtKB:P14618}.
CC   -!- CATALYTIC ACTIVITY: [Isoform M2]:
CC       Reaction=ATP + pyruvate = ADP + H(+) + phosphoenolpyruvate;
CC         Xref=Rhea:RHEA:18157, ChEBI:CHEBI:15361, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:58702, ChEBI:CHEBI:456216;
CC         EC=2.7.1.40; Evidence={ECO:0000250|UniProtKB:P14618};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:18159;
CC         Evidence={ECO:0000250|UniProtKB:P14618};
CC   -!- CATALYTIC ACTIVITY: [Isoform M1]:
CC       Reaction=ATP + pyruvate = ADP + H(+) + phosphoenolpyruvate;
CC         Xref=Rhea:RHEA:18157, ChEBI:CHEBI:15361, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:58702, ChEBI:CHEBI:456216;
CC         EC=2.7.1.40; Evidence={ECO:0000250|UniProtKB:P14618};
CC   -!- CATALYTIC ACTIVITY: [Isoform M2]:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2;
CC         Evidence={ECO:0000250|UniProtKB:P14618};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10597;
CC         Evidence={ECO:0000250|UniProtKB:P14618};
CC   -!- CATALYTIC ACTIVITY: [Isoform M2]:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:P14618};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46609;
CC         Evidence={ECO:0000250|UniProtKB:P14618};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P14618};
CC   -!- COFACTOR:
CC       Name=K(+); Xref=ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000250|UniProtKB:P14618};
CC   -!- ACTIVITY REGULATION: [Isoform M2]: Isoform M2 is allosterically
CC       activated by D-fructose 1,6-bisphosphate (FBP). Inhibited by oxalate
CC       and 3,3',5-triiodo-L-thyronine (T3). The activity of the tetrameric
CC       form is inhibited by PML. Selective binding to tyrosine-phosphorylated
CC       peptides releases the allosteric activator FBP, leading to inhibition
CC       of PKM enzymatic activity, this diverts glucose metabolites from energy
CC       production to anabolic processes when cells are stimulated by certain
CC       growth factors. Glycolytic flux are highly dependent on de novo
CC       biosynthesis of serine and glycine, and serine is a natural ligand and
CC       allosteric activator of isoform M2. {ECO:0000250|UniProtKB:P14618}.
CC   -!- ACTIVITY REGULATION: [Isoform M1]: Has high pyruvate kinase activity by
CC       itself and does not require allosteric activation by D-fructose 1,6-
CC       bisphosphate (FBP) for activity. {ECO:0000250|UniProtKB:P14618}.
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-
CC       glyceraldehyde 3-phosphate: step 5/5. {ECO:0000250|UniProtKB:P14618}.
CC   -!- SUBUNIT: [Isoform M2]: Monomer and homotetramer; exists as a monomer in
CC       the absence of D-fructose 1,6-bisphosphate (FBP), and reversibly
CC       associates to form a homotetramer in the presence of FBP. The monomeric
CC       form binds 3,3',5-triiodo-L-thyronine (T3). Tetramer formation induces
CC       pyruvate kinase activity. The tetrameric form has high affinity for the
CC       substrate and is associated within the glycolytic enzyme complex. FBP
CC       stimulates the formation of tetramers from dimers. Homodimer; exists in
CC       a dimeric form in tumor cells and the dimeric form has less affinity
CC       for the phosphoenolpyruvate substrate. The homodimer converts into a
CC       protein kinase. Interacts with HERC1, POU5F1 and PML. Interacts with
CC       EGLN3; the interaction hydroxylates PKM under hypoxia and enhances
CC       binding to HIF1A. Interacts with HIF1A; the interaction is enhanced by
CC       binding of EGLN3, promoting enhanced transcription activity under
CC       hypoxia. Interacts with TRIM35; this interaction prevents FGFR1-
CC       dependent tyrosine phosphorylation. Interacts with JMJD8. Interacts
CC       with TRAF4. Interacts with (phosphorylated) CTNNB1; leading to activate
CC       transcription. Interacts with TSC22D2; the interaction results in
CC       reduced nuclear levels of PKM isoform M2, leading to repression of
CC       cyclin CCND1 transcription and reduced cell growth (By similarity).
CC       {ECO:0000250|UniProtKB:P14618}.
CC   -!- SUBCELLULAR LOCATION: [Isoform M2]: Cytoplasm
CC       {ECO:0000250|UniProtKB:P14618}. Nucleus {ECO:0000250|UniProtKB:P14618}.
CC       Note=Translocates to the nucleus in response to various signals, such
CC       as EGF receptor activation or apoptotic stimuli.
CC       {ECO:0000250|UniProtKB:P14618}.
CC   -!- SUBCELLULAR LOCATION: [Isoform M1]: Cytoplasm
CC       {ECO:0000250|UniProtKB:P14618}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=M1 {ECO:0000303|PubMed:3020052}; Synonyms=PKM1
CC       {ECO:0000303|PubMed:3020052};
CC         IsoId=P11980-1; Sequence=Displayed;
CC       Name=M2 {ECO:0000303|PubMed:3020052}; Synonyms=PKM2
CC       {ECO:0000303|PubMed:3020052};
CC         IsoId=P11980-2, P11981-1;
CC         Sequence=VSP_011107;
CC   -!- PTM: ISGylated. {ECO:0000250|UniProtKB:P14618}.
CC   -!- PTM: Under hypoxia, hydroxylated by EGLN3.
CC       {ECO:0000250|UniProtKB:P14618}.
CC   -!- PTM: Acetylation at Lys-305 is stimulated by high glucose
CC       concentration, it decreases enzyme activity and promotes its lysosomal-
CC       dependent degradation via chaperone-mediated autophagy.
CC       {ECO:0000250|UniProtKB:P14618}.
CC   -!- PTM: [Isoform M2]: Acetylated by EP300, leading to impair
CC       phosphoenolpyruvate substrate-binding and promote its homodimerization
CC       and subsequent translocation to the nucleus. Deacetylation by SIRT6
CC       promotes its nuclear export into the cytoplasm, leading to suppress its
CC       nuclear localization and oncogenic function.
CC       {ECO:0000250|UniProtKB:P14618}.
CC   -!- PTM: [Isoform M2]: S-nitrosylation at Cys-423 and Cys-424 inhibits
CC       homotetramerization and pyruvate kinase activity (By similarity). S-
CC       nitrosylation is indirectly inhibited by AKR1A1 which degrades S-
CC       nitroso-CoA, a cofactor required to S-nitrosylate proteins (By
CC       similarity). {ECO:0000250|UniProtKB:P14618}.
CC   -!- PTM: FGFR1-dependent tyrosine phosphorylation is reduced by interaction
CC       with TRIM35. {ECO:0000250|UniProtKB:P14618}.
CC   -!- MISCELLANEOUS: There are 4 isozymes of pyruvate kinase in mammals (L,
CC       R, M1, M2) encoded by 2 different genes: PKLR and PKM. The L and R
CC       isozymes are generated from the PKLR by differential splicing of RNA;
CC       the M1 and M2 forms are produced from the PKM gene by differential
CC       splicing. L type is major isozyme in the liver, R is found in red
CC       cells, M1 is the main form in muscle, heart and brain, and M2 is found
CC       in early fetal tissues as well as in most cancer cells.
CC       {ECO:0000250|UniProtKB:P14618}.
CC   -!- SIMILARITY: Belongs to the pyruvate kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M24359; AAB93666.1; -; Genomic_DNA.
DR   EMBL; M24359; AAB93667.1; -; Genomic_DNA.
DR   EMBL; M14377; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X15800; CAA33799.1; -; mRNA.
DR   PIR; A26186; A26186.
DR   PIR; B26186; B26186.
DR   RefSeq; NP_445749.1; NM_053297.2. [P11980-1]
DR   RefSeq; XP_006243250.2; XM_006243188.3.
DR   AlphaFoldDB; P11980; -.
DR   SMR; P11980; -.
DR   BioGRID; 247659; 9.
DR   CORUM; P11980; -.
DR   IntAct; P11980; 6.
DR   MINT; P11980; -.
DR   STRING; 10116.ENSRNOP00000015331; -.
DR   BindingDB; P11980; -.
DR   ChEMBL; CHEMBL4994; -.
DR   MoonProt; P11980; -.
DR   GlyGen; P11980; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P11980; -.
DR   PhosphoSitePlus; P11980; -.
DR   jPOST; P11980; -.
DR   PaxDb; 10116-ENSRNOP00000015331; -.
DR   DNASU; 25630; -.
DR   GeneID; 25630; -.
DR   KEGG; rno:25630; -.
DR   UCSC; RGD:3337; rat. [P11980-1]
DR   AGR; RGD:3337; -.
DR   CTD; 5315; -.
DR   RGD; 3337; Pkm.
DR   VEuPathDB; HostDB:ENSRNOG00000011329; -.
DR   eggNOG; KOG2323; Eukaryota.
DR   HOGENOM; CLU_015439_0_1_1; -.
DR   InParanoid; P11980; -.
DR   OrthoDB; 312683at2759; -.
DR   PhylomeDB; P11980; -.
DR   TreeFam; TF300390; -.
DR   SABIO-RK; P11980; -.
DR   UniPathway; UPA00109; UER00188.
DR   PRO; PR:P11980; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   Bgee; ENSRNOG00000011329; Expressed in skeletal muscle tissue and 19 other cell types or tissues.
DR   ExpressionAtlas; P11980; baseline and differential.
DR   GO; GO:0005929; C:cilium; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:1902912; C:pyruvate kinase complex; IDA:CAFA.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0043531; F:ADP binding; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IDA:CAFA.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0003729; F:mRNA binding; ISS:UniProtKB.
DR   GO; GO:0030955; F:potassium ion binding; IEA:InterPro.
DR   GO; GO:0046983; F:protein dimerization activity; IDA:RGD.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:RHEA.
DR   GO; GO:0004743; F:pyruvate kinase activity; IDA:CAFA.
DR   GO; GO:0070324; F:thyroid hormone binding; IDA:CAFA.
DR   GO; GO:0031100; P:animal organ regeneration; IDA:RGD.
DR   GO; GO:0061621; P:canonical glycolysis; ISO:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IBA:GO_Central.
DR   GO; GO:0006006; P:glucose metabolic process; IDA:RGD.
DR   GO; GO:0006096; P:glycolytic process; IDA:CAFA.
DR   GO; GO:0001889; P:liver development; IDA:RGD.
DR   GO; GO:2000767; P:positive regulation of cytoplasmic translation; ISS:UniProtKB.
DR   GO; GO:1903672; P:positive regulation of sprouting angiogenesis; ISS:UniProtKB.
DR   GO; GO:0012501; P:programmed cell death; ISO:RGD.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:RGD.
DR   GO; GO:0051262; P:protein tetramerization; IDA:RGD.
DR   GO; GO:0042866; P:pyruvate biosynthetic process; IDA:RGD.
DR   GO; GO:0006090; P:pyruvate metabolic process; IDA:RGD.
DR   GO; GO:0009629; P:response to gravity; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0032868; P:response to insulin; IEP:RGD.
DR   GO; GO:0014870; P:response to muscle inactivity; IEP:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   GO; GO:0043403; P:skeletal muscle tissue regeneration; IDA:RGD.
DR   CDD; cd00288; Pyruvate_Kinase; 1.
DR   Gene3D; 3.20.20.60; Phosphoenolpyruvate-binding domains; 1.
DR   Gene3D; 2.40.33.10; PK beta-barrel domain-like; 1.
DR   Gene3D; 3.40.1380.20; Pyruvate kinase, C-terminal domain; 2.
DR   InterPro; IPR001697; Pyr_Knase.
DR   InterPro; IPR015813; Pyrv/PenolPyrv_Kinase-like_dom.
DR   InterPro; IPR040442; Pyrv_Kinase-like_dom_sf.
DR   InterPro; IPR011037; Pyrv_Knase-like_insert_dom_sf.
DR   InterPro; IPR018209; Pyrv_Knase_AS.
DR   InterPro; IPR015793; Pyrv_Knase_brl.
DR   InterPro; IPR015795; Pyrv_Knase_C.
DR   InterPro; IPR036918; Pyrv_Knase_C_sf.
DR   InterPro; IPR015806; Pyrv_Knase_insert_dom_sf.
DR   NCBIfam; TIGR01064; pyruv_kin; 1.
DR   PANTHER; PTHR11817; PYRUVATE KINASE; 1.
DR   PANTHER; PTHR11817:SF101; PYRUVATE KINASE PKM; 1.
DR   Pfam; PF00224; PK; 1.
DR   Pfam; PF02887; PK_C; 1.
DR   PRINTS; PR01050; PYRUVTKNASE.
DR   SUPFAM; SSF51621; Phosphoenolpyruvate/pyruvate domain; 1.
DR   SUPFAM; SSF50800; PK beta-barrel domain-like; 1.
DR   SUPFAM; SSF52935; PK C-terminal domain-like; 1.
DR   PROSITE; PS00110; PYRUVATE_KINASE; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Allosteric enzyme; Alternative splicing; ATP-binding;
KW   Cytoplasm; Direct protein sequencing; Glycolysis; Hydroxylation;
KW   Isopeptide bond; Kinase; Magnesium; Metal-binding; Methylation;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Potassium; Pyruvate;
KW   Reference proteome; S-nitrosylation; Transferase; Translation regulation;
KW   Ubl conjugation.
FT   CHAIN           1..531
FT                   /note="Pyruvate kinase PKM"
FT                   /id="PRO_0000112092"
FT   REGION          307..531
FT                   /note="Interaction with POU5F1"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   REGION          389..433
FT                   /note="Intersubunit contact"
FT   BINDING         70
FT                   /ligand="L-serine"
FT                   /ligand_id="ChEBI:CHEBI:33384"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   BINDING         73
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P30613"
FT   BINDING         75..78
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   BINDING         75
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   BINDING         77
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   BINDING         106
FT                   /ligand="L-serine"
FT                   /ligand_id="ChEBI:CHEBI:33384"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   BINDING         113
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   BINDING         114
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   BINDING         120
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   BINDING         207
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   BINDING         270
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P30613"
FT   BINDING         272
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   BINDING         295
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P30613"
FT   BINDING         296
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   BINDING         296
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P30613"
FT   BINDING         328
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P30613"
FT   BINDING         432..437
FT                   /ligand="beta-D-fructose 1,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:32966"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   BINDING         464
FT                   /ligand="L-serine"
FT                   /ligand_id="ChEBI:CHEBI:33384"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   BINDING         482
FT                   /ligand="beta-D-fructose 1,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:32966"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   BINDING         489
FT                   /ligand="beta-D-fructose 1,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:32966"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   BINDING         516..521
FT                   /ligand="beta-D-fructose 1,6-bisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:32966"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   SITE            270
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000250|UniProtKB:P00549"
FT   MOD_RES         3
FT                   /note="N6,N6,N6-trimethyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         37
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         41
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         62
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         66
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P52480"
FT   MOD_RES         89
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         97
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         100
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         105
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         127
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         148
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P52480"
FT   MOD_RES         166
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         166
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P52480"
FT   MOD_RES         175
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         195
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         266
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         270
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P52480"
FT   MOD_RES         305
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         322
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P52480"
FT   MOD_RES         322
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P52480"
FT   MOD_RES         408
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         475
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P52480"
FT   MOD_RES         498
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P52480"
FT   CROSSLNK        115
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   CROSSLNK        166
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   CROSSLNK        266
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   CROSSLNK        270
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   VAR_SEQ         389..433
FT                   /note="VFHRLLFEELARASSQSTDPLEAMAMGSVEASYKCLAAALIVLTE -> IYH
FT                   LQLFEELRRLAPITSDPTEAAAVGAVEASFKCCSGAIIVLTK (in isoform M2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_011107"
FT   MOD_RES         P11980-2:423
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         P11980-2:424
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
SQ   SEQUENCE   531 AA;  57818 MW;  F0B133FDDD5991A9 CRC64;
     MPKPDSEAGT AFIQTQQLHA AMADTFLEHM CRLDIDSAPI TARNTGIICT IGPASRSVEM
     LKEMIKSGMN VARLNFSHGT HEYHAETIKN VRAATESFAS DPILYRPVAV ALDTKGPEIR
     TGLIKGSGTA EVELKKGATL KITLDNAYME KCDENILWLD YKNICKVVEV GSKIYVDDGL
     ISLQVKEKGA DYLVTEVENG GSLGSKKGVN LPGAAVDLPA VSEKDIQDLK FGVEQDVDMV
     FASFIRKAAD VHEVRKVLGE KGKNIKIISK IENHEGVRRF DEILEASDGI MVARGDLGIE
     IPAEKVFLAQ KMMIGRCNRA GKPVICATQM LESMIKKPRP TRAEGSDVAN AVLDGADCIM
     LSGETAKGDY PLEAVRMQHL IAREAEAAVF HRLLFEELAR ASSQSTDPLE AMAMGSVEAS
     YKCLAAALIV LTESGRSAHQ VARYRPRAPI IAVTRNPQTA RQAHLYRGIF PVLCKDAVLD
     AWAEDVDLRV NLAMNVGKAR GFFKKGDVVI VLTGWRPGSG FTNTMRVVPV P
//
